Flavia Brunstein
Laboratory of Experimental Surgical Oncology
Daniel den Hoed Cancer Center
Erasmus MC
Rotterdam
Netherlands
Name/email consistency: medium
- Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion. Brunstein, F., Hoving, S., aan de Wiel-Ambagtsheer, G., de Bruijn, E.A., Guetens, G., Eggermont, A.M., ten Hagen, T.L. Cancer Immunol. Immunother. (2007)
- Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastases. Brunstein, F., Eggermont, A.M., de Wiel-Ambagtsheer, G., van Tiel, S.T., Rens, J., ten Hagen, T.L. Ann. Surg. Oncol. (2007)
- Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery. Brunstein, F., Rens, J., van Tiel, S.T., Eggermont, A.M., ten Hagen, T.L. Br. J. Cancer (2006)
- Histamine combined with melphalan in isolated limb perfusion for the treatment of locally advanced soft tissue sarcomas: preclinical studies in rats. Brunstein, F., Santos, I.D., Ferreira, L.M., van Tiel, S.T., Eggermont, A.M., Ten Hagen, T.L. Acta. Cir. Bras (2005)